Spots Global Cancer Trial Database for Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
Official Title: A Phase 2 Randomised, Open-label, Multi-centre Ascending Dose Study of the Efficacy, Safety and Tolerability of I-040302 Versus Control Injection (Bone Marrow Aspirate or Steroids) in Children and Young Adults With Solitary Bone Cysts
Study ID: NCT00459641
Conditions
Study Description
Brief Summary: This is a randomised, controlled, open-label study of a single intralesional administration of I-040302 or a single bone marrow aspirate or a single steroid injection (methylprednisolone). Subjects will undergo screening with X-ray and magnetic resonance imaging (MRI) in the diagnosis of a solitary bone cyst.
Detailed Description:
Eligibility
Minimum Age: 6 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Virginia Jamieson, MD
Affiliation: Kuros Biosurgery AG, Technoparkstrasse 1, CH-8005 Zurich
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
